Literature DB >> 11763339

The scientific basis for stopping polio immunisation--issues and challenges.

D J Wood1.   

Abstract

Eradication of polio is in sight. Once this is finally achieved there is general agreement that the world should move from the current policy of universal childhood immunisation, mostly with the oral poliovirus vaccine (OPV), to no immunisation. The challenge ahead is to build consensus on how and when this is achieved. The major area of scientific uncertainty is whether OPV-derived strains excreted by vaccinees will establish chains of transmission in communities, especially in settings of poor hygiene, when population immunity levels begin to fall after immunisation ceases. Evidence from several sources suggests that this may not occur. Most convincing are studies that show polioviruses are not detected beyond three months after mass OPV campaigns in at least two countries that only use OPV in this way. However it is clear that there are significant gaps in our knowledge. These include the transmissibility of OPV-derived strains under certain ecological settings, the potential for persistently infected individuals to re-seed viruses into a community, and the molecular basis of transmissibility. Research in these areas is underway and will help develop and refine strategies for stopping polio immunisation. The potential risks and benefits of ceasing polio immunisation are such that the best available science is required to reach an informed decision.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11763339

Source DB:  PubMed          Journal:  Dev Biol (Basel)        ISSN: 1424-6074


  3 in total

1.  Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine.

Authors:  E A Cherkasova; M L Yakovenko; G V Rezapkin; E A Korotkova; O E Ivanova; T P Eremeeva; L I Krasnoproshina; N I Romanenkova; N R Rozaeva; L Sirota; V I Agol; K M Chumakov
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization.

Authors:  Majid Laassri; Eugenia Dragunsky; Joan Enterline; Tatiana Eremeeva; Olga Ivanova; Kathleen Lottenbach; Robert Belshe; Konstantin Chumakov
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses.

Authors:  Elena Cherkasova; Majid Laassri; Vladimir Chizhikov; Ekaterina Korotkova; Eugenia Dragunsky; Vadim I Agol; Konstantin Chumakov
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.